Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease

[1]  Roy W Jones,et al.  Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease , 2011, International journal of geriatric psychiatry.

[2]  J. Cummings,et al.  Predicting cognitive decline in Alzheimer's disease: An integrated analysis , 2010, Alzheimer's & Dementia.

[3]  J. Cummings,et al.  Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease , 2010, International Psychogeriatrics.

[4]  Gunhild Waldemar,et al.  Rates of Cognitive Change in Alzheimer Disease: Observations Across a Decade of Placebo-controlled Clinical Trials With Donepezil , 2009, Alzheimer disease and associated disorders.

[5]  J. Cummings,et al.  Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer’s Disease , 2009, Dementia and Geriatric Cognitive Disorders.

[6]  M. Shigeta,et al.  Donepezil Treatment of Patients with Severe Alzheimer’s Disease in a Japanese Population: Results from a 24-Week, Double-Blind, Placebo-Controlled, Randomized Trial , 2008, Dementia and Geriatric Cognitive Disorders.

[7]  M. Orrell,et al.  Quality of life in dementia: care recipient and caregiver perceptions of quality of life in dementia: the LASER‐AD study , 2007, International journal of geriatric psychiatry.

[8]  S. E. Black,et al.  Donepezil preserves cognition and global function in patients with severe Alzheimer disease , 2007, Neurology.

[9]  Tetsuji Sato,et al.  Donepezil for severe Alzheimer's disease , 2006, The Lancet.

[10]  Sture Eriksson,et al.  Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study , 2006, The Lancet.

[11]  Anne Whitehead,et al.  Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta‐analysis of individual patient data from randomised controlled trials , 2004, International journal of geriatric psychiatry.

[12]  Xin Yu,et al.  Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. , 2003, The American journal of psychiatry.

[13]  J. Votaw,et al.  Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[14]  P. Tariot,et al.  A Randomized, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting , 2001, Journal of the American Geriatrics Society.

[15]  H. Feldman,et al.  A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease , 2001, Neurology.

[16]  Dirk Deleu,et al.  A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. , 2001, Neurology.

[17]  B. Winblad,et al.  A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD , 2001, Neurology.

[18]  R. Mohs,et al.  A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients , 2001, Neurology.

[19]  S. Starkstein,et al.  Syndromic validity of apathy in Alzheimer's disease. , 2001, The American journal of psychiatry.

[20]  K. Hasegawa,et al.  Clinical Efficacy and Safety of Donepezil on Cognitive and Global Function in Patients with Alzheimer’s Disease , 2000, Dementia and Geriatric Cognitive Disorders.

[21]  D. Geldmacher,et al.  Effect of donepezil treatment on visual attention/exploration tasks in patients with Alzheimer's disease: Results of a pilot study , 2000, Neurobiology of Aging.

[22]  I N Lee,et al.  Data mining techniques applied to medical information , 2000, Medical informatics and the Internet in medicine.

[23]  H.-J. Möller,et al.  The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1 , 1999, Dementia and Geriatric Cognitive Disorders.

[24]  J. Kaye,et al.  The rate of progression of Alzheimer's disease in the later stages: Evidence from the Severe Impairment Battery , 1998, Journal of the International Neuropsychological Society.

[25]  R. Mohs,et al.  A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease , 1998, Neurology.

[26]  L. Friedhoff,et al.  The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial , 1996 .

[27]  J. Cummings,et al.  Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis. , 2010, Journal of Alzheimer's disease : JAD.

[28]  Rachelle S. Doody,et al.  DONEPEZIL STUDY GROUP. A 24-WEEK, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL OF DONEPEZIL IN PATIENTS WITH ALZHEIMER'S DIS-EASE , 1998 .